MERCK SHARP & DOHME CORP: Drug Recall
Recall #D-0746-2022 · 03/31/2022
Class II: Risk
Recall Details
- Recall Number
- D-0746-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- MERCK SHARP & DOHME CORP
- Status
- Terminated
- Date Initiated
- 03/31/2022
- Location
- Whitehouse Station, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3600 cartons
Reason for Recall
Presence of foreign substance: Presence of stainless steel particulates in tablets.
Product Description
Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)
Distribution Pattern
Nationwide in the USA
Other Recalls by MERCK SHARP & DOHME CORP
- Class I: Dangerous 10/19/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.